M&T BANK CORP - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 87 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q2 2020$149,000
+140.3%
13,3330.0%0.00%
Q1 2020$62,000
+8.8%
13,3330.0%0.00%
Q4 2019$57,000
+9.6%
13,3330.0%0.00%
Q3 2019$52,000
-1.9%
13,3330.0%0.00%
Q2 2019$53,000
-8.6%
13,3330.0%0.00%
Q1 2019$58,000
+23.4%
13,3330.0%0.00%
Q4 2018$47,000
-7.8%
13,3330.0%0.00%
Q3 2018$51,000
-1.9%
13,3330.0%0.00%
Q2 2018$52,000
+23.8%
13,3330.0%0.00%
Q1 2018$42,000
-19.2%
13,3330.0%0.00%
Q4 2017$52,000
-5.5%
13,3330.0%0.00%
Q3 2017$55,0000.0%13,3330.0%0.00%
Q2 2017$55,000
-3.5%
13,3330.0%0.00%
Q1 2017$57,000
+67.6%
13,3330.0%0.00%
Q4 2016$34,000
+6.2%
13,3330.0%0.00%
Q3 2016$32,0000.0%13,3330.0%0.00%
Q2 2016$32,000
-11.1%
13,3330.0%0.00%
Q1 2016$36,000
-5.3%
13,3330.0%0.00%
Q4 2015$38,000
+22.6%
13,3330.0%0.00%
Q3 2015$31,000
-35.4%
13,3330.0%0.00%
Q2 2015$48,000
-53.8%
13,333
-42.9%
0.00%
-100.0%
Q1 2015$104,000
-6.3%
23,3330.0%0.00%0.0%
Q4 2014$111,00023,3330.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q3 2020
NameSharesValueWeighting ↓
Weaver Consulting Group 130,000$437,0000.21%
Ikarian Capital, LLC 304,161$1,022,0000.13%
ABNER HERRMAN & BROCK LLC 265,000$890,0000.12%
S.C. Financial Services, Inc. 15,285$51,0000.06%
JMAC ENTERPRISES LLC 45,430$153,0000.04%
CFO4Life Group, LLC 12,000$40,0000.01%
OSAIC HOLDINGS, INC. 10,839$1,329,0000.00%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 3,000$10,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 29,186$98,0000.00%
RAYMOND JAMES & ASSOCIATES 190,403$640,0000.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders